Article Text

other Versions

PDF
Cutaneous leishmaniasis in a returning UK traveller
  1. Rakhi Singh Raghunath1,
  2. Adrian S W Yong1,
  3. Laszlo Igali2,
  4. Eunice Tan1,
  5. Diana Lockwood3
  1. 1Department of Dermatology, Norfolk & Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, UK
  2. 2Department of Cellular Pathology, Norfolk & Norwich University Hospital NHS Foundation Trust, Norwich, UK
  3. 3London School of Hygiene and Tropical Medicine, London, UK
  1. Correspondence to Dr Rakhi Singh Raghunath, Department of Dermatology, Norfolk & Norwich University Hospital NHS Foundation Trust, Colney Lane, Norwich NR4 7UY, UK; dr_rrs2000{at}yahoo.co.uk

Statistics from Altmetric.com

Introduction

The Leishmaniases are diseases caused by protozoan parasites from more than 20 Leishmania (L.) species (order Kinetoplastida) that are transmitted to humans by the bites of infected female Phlebotomine and Lutzomyia sandflies. There are three main forms of the disease: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis and visceral leishmaniasis or kala-azar.1 It is estimated that 0.7–1.2 million of new CL cases and 0.2–0.4 million of new visceral leishmaniasis cases occur each year worldwide.1 CL is classified into Old and New World Cutaneous Leishmaniasis (NWCL) depending on the geographical region where the infection was acquired. NWCL is commonly caused by the L. mexicana complex and L. Viannia subgenus.

The majority of CL cases occur in Afghanistan, Algeria, Brazil, Colombia, the Islamic Republic of Iran, Pakistan, Peru, Saudi …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.